BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31870183)

  • 21. DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma.
    Hale SJM; Perrins RD; Garcı A CE; Pace A; Peral U; Patel KR; Robinson A; Williams P; Ding Y; Saito G; Rodriguez MÁ; Perera I; Barrientos A; Conlon K; Damment S; Porter J; Coulter T
    Bioconjug Chem; 2019 Mar; 30(3):703-713. PubMed ID: 30582799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.
    Yan HM; Song J; Zhang ZH; Jia XB
    Drug Deliv; 2016 Oct; 23(8):2911-2918. PubMed ID: 26644047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.
    Wang B; Zhang W; Zhou X; Liu M; Hou X; Cheng Z; Chen D
    Drug Deliv; 2019 Dec; 26(1):1265-1279. PubMed ID: 31777307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabrication and optimization of itraconazole-loaded zein-based nanoparticles in coated capsules as a promising colon-targeting approach pursuing opportunistic fungal infections.
    Adel S; Fahmy RH; Elsayed I; Mohamed MI; Ibrahim RR
    Drug Deliv Transl Res; 2023 Dec; 13(12):2982-3002. PubMed ID: 37270444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
    Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer.
    Jin G; Jin M; Jin Z; Gao Z; Yin X
    Oncol Rep; 2016 Aug; 36(2):871-6. PubMed ID: 27279008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer.
    Zhu R; Wang Q; Zhu Y; Wang Z; Zhang H; Wu B; Wu X; Wang S
    Acta Biomater; 2016 Jan; 29():320-332. PubMed ID: 26485164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling.
    Chen S; Ren Y; Duan P
    Biomed Pharmacother; 2020 Sep; 129():110371. PubMed ID: 32563984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assembled composite nanoparticles based on zein as delivery vehicles of curcumin: role of chondroitin sulfate.
    Liu C; Yuan Y; Ma M; Zhang S; Wang S; Li H; Xu Y; Wang D
    Food Funct; 2020 Jun; 11(6):5377-5388. PubMed ID: 32469014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An intelligent cell-selective polymersome-DM1 nanotoxin toward triple negative breast cancer.
    Zhang Y; Yue S; Haag R; Sun H; Zhong Z
    J Control Release; 2021 Dec; 340():331-341. PubMed ID: 34774889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
    Tassone P; Gozzini A; Goldmacher V; Shammas MA; Whiteman KR; Carrasco DR; Li C; Allam CK; Venuta S; Anderson KC; Munshi NC
    Cancer Res; 2004 Jul; 64(13):4629-36. PubMed ID: 15231675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curative properties of noninternalizing antibody-drug conjugates based on maytansinoids.
    Perrino E; Steiner M; Krall N; Bernardes GJ; Pretto F; Casi G; Neri D
    Cancer Res; 2014 May; 74(9):2569-78. PubMed ID: 24520075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma.
    El Sharkawi FZ; Ewais SM; Fahmy RH; Rashed LA
    J Drug Target; 2017 Jul; 25(6):513-522. PubMed ID: 28140697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition.
    Jiang Y; Yang N; Zhang H; Sun B; Hou C; Ji C; Zheng J; Liu Y; Zuo P
    J Control Release; 2016 Jan; 221():26-36. PubMed ID: 26643616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erlotinib-Loaded Poly(ε-Caprolactone) Nanocapsules Improve In Vitro Cytotoxicity and Anticlonogenic Effects on Human A549 Lung Cancer Cells.
    Bruinsmann FA; Buss JH; Souto GD; Schultze E; de Cristo Soares Alves A; Seixas FK; Collares TV; Pohlmann AR; Guterres SS
    AAPS PharmSciTech; 2020 Aug; 21(6):229. PubMed ID: 32778976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
    Al-Saden N; Lam K; Chan C; Reilly RM
    Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers.
    Thapa RK; Nguyen HT; Jeong JH; Shin BS; Ku SK; Choi HG; Yong CS; Kim JO
    Nanomedicine; 2017 Apr; 13(3):885-896. PubMed ID: 27993720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of pemetrexed by magnetic nanoparticles: design, characterization,
    Ak G; Aksu D; Çapkın E; Sarı Ö; Kımız Geboloğlu I; Şanlıer ŞH
    Prep Biochem Biotechnol; 2020; 50(3):215-225. PubMed ID: 31750758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.